Scarica l'app Stockscreener
78.92
1.54%
1.20
Dopo l'orario di chiusura:
79.22
0.30
+0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZTS Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$77.72
Aprire:
$79.85
Volume 24 ore:
7.29M
Relative Volume:
1.39
Capitalizzazione di mercato:
$33.09B
Reddito:
$9.51B
Utile/perdita netta:
$2.64B
Rapporto P/E:
13.07
EPS:
6.0361
Flusso di cassa netto:
$2.14B
1 W Prestazione:
+2.57%
1M Prestazione:
-35.51%
6M Prestazione:
-32.59%
1 anno Prestazione:
-51.86%
Intervallo 1D:
$77.59
$80.36
Intervallo di 1 settimana:
$72.38
$80.36
Portata 52W:
$72.38
$172.23
Zoetis Inc Stock (ZTS) Company Profile
Nome
Zoetis Inc
Settore
Telefono
973-822-7000
Indirizzo
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
78.92 | 32.58B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
16.58 | 52.36B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.20 | 40.62B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.63B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
566.80 | 24.07B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Downgrade | Stifel | Buy → Hold |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-12 | Reiterato | Stifel | Buy |
| 2023-12-19 | Ripresa | Jefferies | Buy |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-03-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Iniziato | Atlantic Equities | Overweight |
| 2020-08-14 | Aggiornamento | Edward Jones | Hold → Buy |
| 2020-08-12 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Iniziato | Jefferies | Buy |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-09-09 | Iniziato | Goldman | Buy |
| 2019-07-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2019-05-03 | Downgrade | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-03-04 | Aggiornamento | Stifel | Hold → Buy |
| 2019-01-23 | Iniziato | UBS | Neutral |
| 2018-10-15 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Downgrade | Stifel | Buy → Hold |
| 2018-08-03 | Reiterato | Stifel | Buy |
| 2018-04-19 | Reiterato | Citigroup | Buy |
| 2018-03-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Reiterato | Stifel | Buy |
| 2018-01-04 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Zoetis Inc Borsa (ZTS) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zoetis, Inc. (ZTS) And Encourages Stockholders to Connect - The National Law Review
New FDA Authorization Broadens Zoetis Screwworm Treatment Options - Successful Farming
A Look At Zoetis (ZTS) Valuation After Soft Q1 Results And Lower 2026 Guidance - simplywall.st
Zoetis Inc (NYSE:ZTS): A Dividend Growth Stock with Strong Profitability and Attractive Valuation - ChartMill
Zoetis Inc (ZTS) Shares Surge 4.7% -- What GF Score of 83 Tells Investors - GuruFocus
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
FinancialContentZoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Zoetis' Wide Moat Remains Intact, but We've Lowered Our Fair Value Estimate - Morningstar
Citigroup Adjusts Price Target on Zoetis to $112 From $145, Maintains Buy Rating - Moomoo
Why Zoetis (ZTS) Is Down 10.4% After Trimming 2026 Outlook Amid Weaker Pet Demand - simplywall.st
Zoetis Inc. stock underperforms Monday when compared to competitors - MSN
5 Revealing Analyst Questions From Zoetis’s Q1 Earnings Call - Yahoo Finance
Stoneridge Investment Partners LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Saratoga Research & Investment Management - MarketBeat
Zoetis Inc. $ZTS Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
(ZTS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Zoetis Drops to 52-Week Low, Monday Open in Focus - TechStock²
Zoetis Stock at Support Zone – Bargain or Trap? - Trefis
Zoetis (ZTS) Valuation Reset After Q1 Earnings Miss And Guidance Cut - Yahoo Finance
Marathon, Coherent, Senseonics, KLA, Zoetis Insider Shakeup - TipRanks
Zoetis Stock Hits Key SupportBuying Opportunity? - Trefis
Novare Capital Management LLC Trims Stake in Zoetis Inc. $ZTS - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Atria Investments Inc Sells 24,176 Shares of Zoetis Inc. $ZTS - MarketBeat
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – - The National Law Review
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Morgan Stanley Adjusts Price Target on Zoetis to $115 From $160, Maintains Overweight Rating - Moomoo
Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $75.48 - Moomoo
Zoetis Inc. Stock 12‑Month Price Target Cut to $126.07, Implies 67% Upside - TradingView
Zoetis, Inc. Stock Plummets to New 52-Week Low of $85.33 - Markets Mojo
Why S&P 500 Attention Is Turning Toward Zoetis Growth? - Kalkine Media
Zoetis stock hits 52-week low at $74.29 amid market fluctuations - Investing.com
Jim Cramer Calls Zoetis a “Quality Company” Despite Recent Declines - Insider Monkey
Zoetis shares plunge 21.5% after slashing 2026 revenue guidance amid pet-care demand slowdown - Pluang
Here is Why Zoetis (ZTS) is One of the Best NYSE Stocks According Analysts - Yahoo Finance
Zoetis (ZTS) Securities Fraud InvestigationLevi & Korsinsky - Sahm
Pacer Advisors Inc. Raises Stake in Zoetis Inc. $ZTS - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 13,580 Shares of Zoetis Inc. $ZTS - MarketBeat
ZTS Technical Analysis | Trend, Signals & Chart Patterns | ZOETIS INC (NYSE:ZTS) - ChartMill
Insider Buying: Frank Damelio Acquires Shares of Zoetis Inc (ZTS) - GuruFocus
Zoetis director Frank A. Damelio buys $501,343 in company stock By Investing.com - Investing.com South Africa
Zoetis director Paul Bisaro purchases $151,750 in ZTS stock By Investing.com - Investing.com Nigeria
Zoetis director Paul Bisaro purchases $151,750 in ZTS stock - Investing.com
Zoetis director Frank A. Damelio buys $501,343 in company stock - Investing.com
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis Director Purchased Shares Worth Over $501K - TradingView
Zoetis (ZTS) director Frank D'Amelio buys 6,650 shares in open market - Stock Titan
[Form 4] Zoetis Inc. Insider Trading Activity - Stock Titan
Earnings call transcript: Zoetis misses Q1 2026 EPS forecast, stock drops - Investing.com
Major Purchase Alert: MICHAEL MCCALLISTER Invests $233K In Zoetis Stock - Benzinga
First National Advisers LLC Sells 28,062 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc Azioni (ZTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):